BCL2L1 and colorectal carcinoma: Accordingly, targeting the Wnt pathway by BMP7v curtails the clonogenic activity of CD44v6+ CRC cells and leads to their terminal differentiation, as highlighted by the presence of PARP activation and downregulation of the antiapoptotic proteins Bcl-2 and Bcl-xL.